Choices in medical management for prevention of acute ischemic stroke.

J. D. Fleck, J. Biller

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations

Abstract

Stroke is a leading cause of death and disability. Although advances are being made in the treatment of acute ischemic stroke, its prevention is equally as important. Identification and management of risk factors are essential. Medical therapy is also helpful in the secondary prevention of ischemic stroke. There are currently four platelet-antiaggregating agents used to prevent ischemic stroke: aspirin, aspirin plus dipyridamole, clopidogrel, and ticlopidine. The relevant studies proving their efficacy are noted, as are some of their similarities and differences. The use of warfarin is also discussed.

Original languageEnglish (US)
Pages (from-to)33-38
Number of pages6
JournalCurrent neurology and neuroscience reports
Volume1
Issue number1
DOIs
StatePublished - Jan 2001

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Choices in medical management for prevention of acute ischemic stroke.'. Together they form a unique fingerprint.

Cite this